Co-Diagnostics Total Non-Operating Income/Expense 2017-2025 | CODX
Co-Diagnostics Annual Total Non-Operating Income/Expense (Millions of US $) |
|
---|---|
2024 | $3 |
2023 | $5 |
2022 | $8 |
2021 | $0 |
2020 | $1 |
2019 | $0 |
2018 | $0 |
2017 | $-2 |
2016 | $0 |
Co-Diagnostics Quarterly Total Non-Operating Income/Expense (Millions of US $) |
|
---|---|
2025-03-31 | $1 |
2024-12-31 | $1 |
2024-09-30 | $1 |
2024-06-30 | $0 |
2024-03-31 | $1 |
2023-12-31 | $1 |
2023-09-30 | $1 |
2023-06-30 | $1 |
2023-03-31 | $2 |
2022-12-31 | $1 |
2022-09-30 | $3 |
2022-06-30 | $1 |
2022-03-31 | $3 |
2021-12-31 | $0 |
2021-09-30 | $0 |
2021-06-30 | $0 |
2021-03-31 | $0 |
2020-12-31 | $0 |
2020-09-30 | $1 |
2020-06-30 | $0 |
2020-03-31 | $0 |
2019-12-31 | $0 |
2019-09-30 | $0 |
2019-06-30 | $0 |
2019-03-31 | $0 |
2018-12-31 | $0 |
2018-09-30 | $0 |
2018-06-30 | $0 |
2018-03-31 | $0 |
2017-12-31 | $0 |
2017-09-30 | $-2 |
2017-06-30 | $0 |
2017-03-31 | $0 |
2016-12-31 | |
2016-09-30 | $0 |
2016-06-30 | $0 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $0.009B | $0.004B |
Co-Diagnostics Inc. is a molecular diagnostics company. It develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company's technology is utilized for tests which are designed using the detection and/or analysis of nucleic acid molecules. It also uses proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers. Co-Diagnostics Inc. is based in UT, United States. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Danaher (DHR) | United States | $147.306B | 27.32 |
CVS Health (CVS) | United States | $83.088B | 10.33 |
Elevance Health (ELV) | United States | $65.860B | 8.86 |
Cencora (COR) | United States | $56.044B | 18.67 |
DiDi Global (DIDIY) | China | $26.733B | 28.40 |
Labcorp Holdings (LH) | United States | $22.380B | 17.79 |
Natera (NTRA) | United States | $21.934B | 0.00 |
BioMerieux (BMXMF) | France | $17.238B | 0.00 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $15.271B | 0.00 |
ICON (ICLR) | Ireland | $13.654B | 13.14 |
CochLear (CHEOY) | Australia | $13.302B | 0.00 |
Medpace Holdings (MEDP) | United States | $12.903B | 34.15 |
Solventum (SOLV) | United States | $12.500B | 12.90 |
Viatris (VTRS) | United States | $11.799B | 4.20 |
Revvity (RVTY) | United States | $10.214B | 18.00 |
Sonic Healthcare (SKHHY) | Australia | $9.176B | 0.00 |
Avantor (AVTR) | United States | $8.631B | 12.66 |
Caris Life Sciences,�Inc (CAI) | United States | $8.258B | 0.00 |
HealthEquity (HQY) | United States | $8.040B | 35.22 |
Charles River Laboratories (CRL) | United States | $7.517B | 14.26 |
Bausch + Lomb (BLCO) | Canada | $4.874B | 32.79 |
Sotera Health (SHC) | United States | $4.221B | 23.59 |
Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.83 |
BrightSpring Health Services (BTSG) | United States | $3.848B | 29.35 |
GeneDx Holdings (WGS) | United States | $3.344B | 76.59 |
Surgery Partners (SGRY) | United States | $2.946B | 37.06 |
Alignment Healthcare (ALHC) | United States | $2.899B | 0.00 |
Concentras Parent (CON) | United States | $2.871B | 18.21 |
Organon (OGN) | United States | $2.353B | 2.56 |
Premier (PINC) | United States | $1.978B | 15.01 |
Progyny (PGNY) | United States | $1.873B | 39.60 |
Ardent Health (ARDT) | United States | $1.785B | 6.89 |
PACS (PACS) | United States | $1.705B | 0.00 |
Pediatrix Medical (MD) | United States | $1.282B | 8.56 |
GoodRx Holdings (GDRX) | United States | $1.250B | 20.59 |
Teladoc Health (TDOC) | United States | $1.214B | 0.00 |
Establishment Labs Holdings (ESTA) | $0.974B | 0.00 | |
Ryman Healthcare (RYHTY) | New Zealand | $0.965B | 0.00 |
Embecta (EMBC) | United States | $0.779B | 4.56 |
AMN Healthcare Services Inc (AMN) | United States | $0.676B | 8.36 |
CareDx (CDNA) | United States | $0.663B | 12.22 |
Performant Healthcare (PHLT) | United States | $0.602B | 0.00 |
QDM (QDMI) | Hong Kong, SAR China | $0.583B | 200.00 |
Nutex Health (NUTX) | United States | $0.534B | 8.08 |
Omada Health (OMDA) | $0.497B | 0.00 | |
So-Young (SY) | China | $0.488B | 0.00 |
InnovAge Holding (INNV) | United States | $0.485B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.480B | 0.00 |
SBC Medicals (SBC) | United States | $0.470B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.467B | 10.52 |
COMPASS Pathways (CMPS) | United Kingdom | $0.405B | 0.00 |
Enhabit (EHAB) | United States | $0.382B | 25.13 |
Agilon Health (AGL) | United States | $0.369B | 0.00 |
Oncology Institute (TOI) | United States | $0.367B | 0.00 |
LifeMD (LFMD) | United States | $0.324B | 0.00 |
Beauty Health (SKIN) | United States | $0.292B | 0.00 |
Shoulder Innovations (SI) | United States | $0.200B | 0.00 |
DocGo (DCGO) | United States | $0.169B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.129B | 0.00 |
KindlyMD (NAKA) | United States | $0.084B | 0.00 |
Sera Prognostics (SERA) | United States | $0.084B | 0.00 |
NeueHealth (NEUE) | United States | $0.061B | 0.00 |
Biodesix (BDSX) | United States | $0.060B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.048B | 0.00 |
Basel Medical Group (BMGL) | Singapore | $0.040B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.040B | 0.00 |
ModivCare (MODV) | United States | $0.033B | 0.00 |
OSR Holdings (OSRH) | United States | $0.011B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
XWELL (XWEL) | United States | $0.007B | 0.00 |
Pheton Holdings (PTHL) | China | $0.005B | 0.00 |
Aclarion (ACON) | United States | $0.004B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
INVO Fertility (IVF) | United States | $0.001B | 0.00 |
Cano Health (CANOQ) | United States | $0.000B | 0.00 |